Granules India Limited has informed the Exchange regarding a press release dated May 07, 2025, titled "Granules India Earns Gold Rating in First-Ever Corporate-Level EcoVadis AssessmentRanks in the Top 5% Globally Across All Industries".
GRANULES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Granules India Limited has been awarded a Gold rating by EcoVadis in its first-ever corporate-level sustainability assessment, placing it in the 97th percentile among the top 5% of all companies assessed globally across all industries. EcoVadis evaluated the company on four pillars: environment, labour and human rights, ethics, and sustainable procurement. The recognition highlights Granules' existing sustainability practices including science-based climate targets, greener chemistry platforms, and safer workplace practices. This builds on the company's vertically integrated pharmaceutical operations spanning 10 manufacturing facilities (8 in India, 2 in the USA), serving over 80 countries. Company leadership framed this as a milestone reinforcing their purpose of 'Healing lives responsibly through pioneering green science'.
This is a non-financial ESG milestone with no direct impact on earnings or stock price, but it strengthens Granules' reputation with global pharma buyers and procurement teams who increasingly use EcoVadis scores in vendor selection, which could support long-term business development.